Guelph, Canada Clinical Trials

A listing of Guelph, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 48 clinical trials
Promoting Reengagement in Daily Meaningful Activity Intervention for adults with mild cognitive impairment and their caregivers

The PRIMA project is design to help persons with mild cognitive impairment to help them to improve their engagement in personally meaningful activity and improve their overall quality of life with their family caregivers support. The goal of PRIMA project is to increase persons with mild cognitive impairment’s engagement in …

Accepts healthy volunteers
Online studies
Online Study Center
(online study) Contact site
  • 23 Sep, 2022
  • 1 location
  • Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)

This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …

Online studies
movement disorder
University of Rochester
(online study) Contact site
  • 12 May, 2022
  • 1 location
  • Online study
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]

This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etripamil NS self-administered by patients who experience an episode of paroxysmal ventricular tachycardia (PSVT) in an at-home setting. Part 1 comprised the conduct of the NODE-301 study up to the date of the adjudication …

Dawson Road Medical Centre
 (1.5 away) Contact site
  • 28 Feb, 2022
  • +90 other locations
A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) (VICTORION-2P)

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).

Novartis Investigative Site
 (0.1 away) Contact site
  • 14 Sep, 2022
  • +582 other locations
A Randomised, Double-blind, Placebo-controlled, Multi-center Sequential Phase 2b and Phase 3 Study to Evaluate the Efficacy and Safety of AZD4831 Administered for Up to 48 Weeks in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40% (ENDEAVOR)

This is a randomised, double-blind, placebo-controlled, multi-center sequential phase 2b and Phase 3 study to evaluate the efficacy and safety of AZD4831 administered for up to 48 Weeks in participants with heart failure with left ventricular ejection fraction > 40%. The study will consist of 2 separate parts, Part A …

Research site
 (0.1 away) Contact site
  • 19 Sep, 2022
  • +118 other locations
The Effects of Acetaminophen on Fear

This study investigates the effects of acetaminophen on behavioral, physiological, and self-report fear responses.

Accepts healthy volunteers
  • 17 Jun, 2022
  • 1 location
Factors That Influence Blood Vessel Regulation During Exercise in Humans

This study will examine the effects of ischemic preconditioning or a high fat meal on the capacity of the brachial artery to overcome sympathetic activation and dilate during exercise (also known as functional sympatholysis). Participants will be asked to complete rhythmic handgrip exercise with and without the application of -20 …

Accepts healthy volunteers
University of Guelph - Human Cardiovascular Physiology Laboratory
 (1.6 away) Contact site
  • 14 Jul, 2022
  • 1 location
Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

This is a phase IV, 12-month observational, prospective, open-label, multi-center study that will be conducted across approximately 50 sites in Canada for an estimated study duration of 32 months. All eligible adult participants who are enrolling into the SILIQ Patient Support Program (PSP) and initiating brodalumab as per routine care …

plaque psoriasis
CARE Site 20
 (4.2 away) Contact site
  • 22 Dec, 2021
  • +9 other locations